Lv5
1180 积分 2024-05-23 加入
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
1个月前
已完结
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
2个月前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
2个月前
已完结
生物制剂治疗慢性鼻窦炎伴鼻息肉专家共识（2025）
4个月前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
6个月前
已完结
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
6个月前
已完结
Alternative pathway amplification and infections
7个月前
已完结
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
11个月前
已完结
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis
11个月前
已完结
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
11个月前
已完结
皖公网安备34019202002308
